GlaxoSmithKline opened its new $56.6 million vaccines plant in Montrose, Scotland, that will manufacture sterile aluminum salts and includes a microbiology lab. But the small addition comes as a much bigger project has been canceled.
{iframe}http://www.fiercepharma.com/manufacturing/gsk-opens-new-56-6m-vaccines-plant-scotland{/iframe}